TuHURA Biosciences, Inc./NV SEC filings HURA
TuHURA Biosciences, Inc./NV has 928 filings in SEC EDGAR's recent list, going back to Aug 17, 2010. Its latest annual report, Form ARS, was filed on Jul 9, 2026 for the period ended Dec 31, 2025. The latest quarterly report (Form 10-Q) was filed on Aug 14, 2026, covering the quarter ended Jun 30, 2026. The most recent current report (Form 8-K) was filed on Oct 16, 2026 (new debt). The company's fiscal year ends on December 31.
| Form | Description | Filed | Period |
|---|---|---|---|
| 8-K |
Current report
New debt
|
Oct 16, 2026 | Oct 9, 2026 |
| 8-K |
Current report
New debt
|
Sep 24, 2026 | Sep 21, 2026 |
| 8-K |
Current report
New debt
|
Sep 17, 2026 | Sep 14, 2026 |
| 8-K/A |
Amended current report
Officer or director change
|
Sep 17, 2026 | Sep 10, 2026 |
| 8-K |
Current report
Officer or director change
|
Sep 16, 2026 | Sep 10, 2026 |
| 8-K |
Current report
New debt
|
Sep 4, 2026 | Sep 2, 2026 |
| 8-K |
Current report
New debt
|
Aug 21, 2026 | Aug 20, 2026 |
| 8-K |
Current report
Unregistered share sale, Shareholder vote results
|
Aug 19, 2026 | Aug 18, 2026 |
| 10-Q | Quarterly report | Aug 14, 2026 | Jun 30, 2026 |
| 8-K |
Current report
Results of operations
|
Aug 14, 2026 | Aug 14, 2026 |
| 8-K |
Current report
New debt
|
Aug 13, 2026 | Aug 7, 2026 |
| 8-K |
Current report
New debt
|
Jul 29, 2026 | Jul 28, 2026 |
| ARS | Annual report to shareholders | Jul 9, 2026 | Dec 31, 2025 |
| DEFA14A | Additional proxy material | Jul 9, 2026 | — |
| DEF 14A | Proxy statement | Jul 9, 2026 | Aug 18, 2026 |
| 8-K |
Current report
New debt
|
Jul 7, 2026 | Jun 30, 2026 |
| PRE 14A | Preliminary proxy statement | Jun 26, 2026 | Aug 18, 2026 |
| 8-K | Current report | Jun 17, 2026 | Jun 17, 2026 |
| 8-K |
Current report
New debt
|
May 29, 2026 | May 26, 2026 |
| 10-Q | Quarterly report | May 15, 2026 | Mar 31, 2026 |
| 8-K |
Current report
Results of operations, Regulation FD disclosure
|
May 15, 2026 | May 15, 2026 |
| 8-K/A |
Amended current report
Other events
|
Apr 30, 2026 | Apr 2, 2026 |
| 10-K/A | Amended annual report | Apr 30, 2026 | Dec 31, 2025 |
| 8-K |
Current report
Material agreement, New debt, Unregistered share sale, Regulation FD disclosure
|
Apr 22, 2026 | Apr 21, 2026 |
| 424B5 | Prospectus supplement | Apr 8, 2026 | — |
| 8-K |
Current report
Officer or director change, Other events
|
Apr 8, 2026 | Apr 2, 2026 |
| 8-K |
Current report
Results of operations
|
Apr 1, 2026 | Apr 1, 2026 |
| 10-K | Annual report | Mar 31, 2026 | Dec 31, 2025 |
| 8-K |
Current report
Listing notice
|
Jan 30, 2026 | Jan 29, 2026 |
| 8-K |
Current report
Material agreement, Other events
|
Dec 10, 2025 | Dec 9, 2025 |
| 424B5 | Prospectus supplement | Dec 10, 2025 | — |
| 8-K |
Current report
Material agreement, New debt
|
Dec 5, 2025 | Dec 2, 2025 |
| 8-K |
Current report
Regulation FD disclosure
|
Nov 25, 2025 | Nov 25, 2025 |
| 424B3 | Prospectus | Nov 25, 2025 | — |
| 8-K |
Current report
Other events
|
Nov 18, 2025 | Nov 18, 2025 |
| 10-Q | Quarterly report | Nov 14, 2025 | Sep 30, 2025 |
| 8-K |
Current report
Results of operations
|
Nov 14, 2025 | Nov 14, 2025 |
| D | Filing | Nov 10, 2025 | — |
| 8-K |
Current report
Material agreement
|
Nov 4, 2025 | Nov 3, 2025 |
| S-3 | Shelf registration | Nov 3, 2025 | — |
| 8-K |
Current report
Other events
|
Nov 3, 2025 | Nov 3, 2025 |
| 424B3 | Prospectus | Oct 31, 2025 | — |
| 8-K |
Current report
Material agreement, New debt
|
Oct 31, 2025 | Oct 27, 2025 |
| EFFECT | Filing | Sep 26, 2025 | — |
| 424B3 | Prospectus | Sep 26, 2025 | — |
| UPLOAD | Letter from the SEC | Sep 25, 2025 | — |
| CORRESP | Letter to the SEC | Sep 24, 2025 | — |
| CORRESP | Letter to the SEC | Sep 18, 2025 | — |
| S-1/A | Amended registration statement | Sep 18, 2025 | — |
| 8-K |
Current report
Material agreement
|
Sep 11, 2025 | Sep 5, 2025 |
| UPLOAD | Letter from the SEC | Aug 28, 2025 | — |
| CORRESP | Letter to the SEC | Aug 25, 2025 | — |
| UPLOAD | Letter from the SEC | Aug 20, 2025 | — |
| 10-Q | Quarterly report | Aug 14, 2025 | Jun 30, 2025 |
| 8-K |
Current report
Results of operations
|
Aug 14, 2025 | Aug 14, 2025 |
| S-1 | Registration statement | Aug 12, 2025 | — |
| 8-K/A | Amended current report | Aug 12, 2025 | Jun 30, 2025 |
| 8-K |
Current report
Acquisition or sale of assets, Regulation FD disclosure
|
Jun 30, 2025 | Jun 30, 2025 |
| 8-K |
Current report
Bylaw or fiscal year change
|
Jun 27, 2025 | Jun 23, 2025 |
| 425 | Filing | Jun 24, 2025 | — |
| 8-K |
Current report
Shareholder vote results, Regulation FD disclosure
|
Jun 24, 2025 | Jun 23, 2025 |
| D | Filing | Jun 13, 2025 | — |
| 8-K | Current report | Jun 12, 2025 | Jun 6, 2025 |
| 425 | Filing | Jun 6, 2025 | — |
| 8-K |
Current report
Material agreement, Unregistered share sale, Regulation FD disclosure
|
Jun 6, 2025 | Jun 2, 2025 |
| 425 | Filing | Jun 3, 2025 | — |
| ARS | Annual report to shareholders | May 23, 2025 | Dec 31, 2024 |
| 424B3 | Prospectus | May 23, 2025 | — |
| 10-Q | Quarterly report | May 15, 2025 | Mar 31, 2025 |
| 425 | Filing | May 15, 2025 | — |
| 8-K |
Current report
Results of operations
|
May 15, 2025 | May 15, 2025 |
| EFFECT | Filing | May 14, 2025 | — |
| 425 | Filing | May 13, 2025 | — |
| CORRESP | Letter to the SEC | May 12, 2025 | — |
| S-4/A | Filing | May 8, 2025 | — |
| 8-K/A |
Amended current report
Officer or director change
|
May 7, 2025 | Mar 7, 2025 |
| 425 | Filing | May 7, 2025 | — |
| 8-K |
Current report
Material agreement, Officer or director change
|
May 7, 2025 | May 5, 2025 |
| CORRESP | Letter to the SEC | May 6, 2025 | — |
| S-4/A | Filing | May 6, 2025 | — |
| 425 | Filing | May 5, 2025 | — |
| 425 | Filing | Apr 28, 2025 | — |
| 425 | Filing | Apr 8, 2025 | — |
| 425 | Filing | Apr 1, 2025 | — |
| 8-K |
Current report
Results of operations
|
Apr 1, 2025 | Apr 1, 2025 |
| 10-K | Annual report | Mar 31, 2025 | Dec 31, 2024 |
| 8-K |
Current report
Regulation FD disclosure
|
Mar 18, 2025 | Mar 18, 2025 |
| 8-K |
Current report
Officer or director change, Regulation FD disclosure
|
Mar 12, 2025 | Mar 7, 2025 |
| UPLOAD | Letter from the SEC | Feb 20, 2025 | — |
| 8-K |
Current report
Material agreement
|
Feb 14, 2025 | Feb 12, 2025 |
| S-4 | Registration for a merger or exchange | Feb 7, 2025 | — |
| 8-K |
Current report
Auditor change
|
Jan 3, 2025 | Dec 27, 2024 |
| S-8 | Employee stock plan registration | Dec 23, 2024 | — |
| 425 | Filing | Dec 12, 2024 | — |
| 8-K |
Current report
Material agreement, Regulation FD disclosure
|
Dec 12, 2024 | Dec 11, 2024 |
| 8-K |
Current report
Regulation FD disclosure
|
Nov 25, 2024 | Nov 25, 2024 |
| 8-K |
Current report
Officer or director change
|
Nov 15, 2024 | Nov 15, 2024 |
| 8-K/A |
Amended current report
Acquisition or sale of assets
|
Nov 14, 2024 | Oct 18, 2024 |
| 10-Q | Quarterly report | Nov 14, 2024 | Sep 30, 2024 |
| 8-K |
Current report
Material agreement, Acquisition or sale of assets, Results of operations, Change to shareholder rights, Change in control, Officer or director change, Bylaw or fiscal year change, Other events
|
Oct 21, 2024 | Oct 18, 2024 |
| EFFECT | Filing | Oct 15, 2024 | — |
| 8-K |
Current report
Regulation FD disclosure, Other events
|
Oct 15, 2024 | Oct 15, 2024 |
| 8-K |
Current report
Regulation FD disclosure, Other events
|
Oct 15, 2024 | Oct 14, 2024 |
| POS AM | Filing | Oct 8, 2024 | — |
| 8-K |
Current report
Other events
|
Oct 8, 2024 | Oct 8, 2024 |
| 8-K |
Current report
Results of operations, Regulation FD disclosure
|
Oct 8, 2024 | Oct 8, 2024 |
| 10-K | Annual report | Oct 7, 2024 | Jun 30, 2024 |
| 425 | Filing | Oct 4, 2024 | — |
| 8-K |
Current report
Shareholder vote results
|
Oct 4, 2024 | Oct 4, 2024 |
| NT 10-K | Filing | Sep 30, 2024 | Jun 30, 2024 |
| 424B3 | Prospectus | Sep 25, 2024 | — |
| 425 | Filing | Sep 25, 2024 | — |
| 8-K |
Current report
Material agreement
|
Sep 25, 2024 | Sep 25, 2024 |
| 425 | Filing | Sep 24, 2024 | — |
| 8-K |
Current report
Regulation FD disclosure
|
Sep 24, 2024 | Sep 24, 2024 |
| 425 | Filing | Sep 20, 2024 | — |
| 8-K |
Current report
Shareholder vote results, Regulation FD disclosure
|
Sep 20, 2024 | Sep 20, 2024 |
| 425 | Filing | Sep 19, 2024 | — |
| 8-K |
Current report
Regulation FD disclosure
|
Sep 19, 2024 | Sep 18, 2024 |
| 425 | Filing | Sep 18, 2024 | — |
| 8-K |
Current report
Regulation FD disclosure
|
Sep 18, 2024 | Sep 18, 2024 |
| 425 | Filing | Sep 11, 2024 | — |
| 8-K |
Current report
Regulation FD disclosure, Other events
|
Sep 11, 2024 | Sep 11, 2024 |
| 425 | Filing | Sep 9, 2024 | — |
| 8-K |
Current report
Regulation FD disclosure
|
Sep 9, 2024 | Sep 9, 2024 |
| 425 | Filing | Sep 3, 2024 | — |
| 8-K |
Current report
Regulation FD disclosure
|
Sep 3, 2024 | Sep 3, 2024 |
| 425 | Filing | Aug 19, 2024 | — |
| 8-K |
Current report
Regulation FD disclosure, Other events
|
Aug 19, 2024 | Aug 19, 2024 |
| 424B3 | Prospectus | Aug 19, 2024 | — |
| SEC STAFF LETTER | Filing | Aug 13, 2024 | — |
| EFFECT | Filing | Aug 13, 2024 | — |
| CORRESP | Letter to the SEC | Aug 12, 2024 | — |
| S-4/A | Filing | Aug 12, 2024 | — |
| CORRESP | Letter to the SEC | Aug 8, 2024 | — |
| S-4/A | Filing | Aug 8, 2024 | — |
| UPLOAD | Letter from the SEC | Aug 1, 2024 | — |
| CORRESP | Letter to the SEC | Jul 19, 2024 | — |
| S-4/A | Filing | Jul 19, 2024 | — |
| 8-K |
Current report
Bylaw or fiscal year change
|
Jul 12, 2024 | Jul 12, 2024 |
| UPLOAD | Letter from the SEC | Jul 10, 2024 | — |
| 425 | Filing | Jul 8, 2024 | — |
| 8-K |
Current report
Regulation FD disclosure, Other events
|
Jul 8, 2024 | Jul 3, 2024 |
| 425 | Filing | Jul 1, 2024 | — |
| 8-K |
Current report
Regulation FD disclosure, Other events
|
Jul 1, 2024 | Jul 1, 2024 |
| CORRESP | Letter to the SEC | Jun 27, 2024 | — |
| S-4/A | Filing | Jun 27, 2024 | — |
| 8-K |
Current report
Shareholder vote results
|
Jun 24, 2024 | Jun 20, 2024 |
| 425 | Filing | Jun 13, 2024 | — |
| 8-K |
Current report
Listing notice
|
Jun 13, 2024 | Jun 12, 2024 |
| SEC STAFF LETTER | Filing | Jun 10, 2024 | — |
| UPLOAD | Letter from the SEC | Jun 7, 2024 | — |
| 425 | Filing | Jun 3, 2024 | — |
| 8-K |
Current report
Regulation FD disclosure
|
Jun 3, 2024 | Jun 3, 2024 |
| ARS | Annual report to shareholders | May 17, 2024 | Jun 30, 2023 |
| DEF 14A | Proxy statement | May 17, 2024 | Jun 20, 2024 |
| 425 | Filing | May 14, 2024 | — |
| 8-K |
Current report
Results of operations, Regulation FD disclosure
|
May 14, 2024 | May 14, 2024 |
| 10-Q | Quarterly report | May 14, 2024 | Mar 31, 2024 |
| S-4 | Registration for a merger or exchange | May 13, 2024 | — |
| 8-K | Current report | May 9, 2024 | May 5, 2024 |
| 8-K |
Current report
Regulation FD disclosure
|
Apr 25, 2024 | Apr 25, 2024 |
| 425 | Filing | Apr 25, 2024 | — |
| 425 | Filing | Apr 3, 2024 | — |
| 8-K |
Current report
Material agreement, Officer or director change, Regulation FD disclosure, Other events
|
Apr 3, 2024 | Apr 2, 2024 |
| RW | Filing | Mar 13, 2024 | — |
| 8-K |
Current report
Other events
|
Feb 27, 2024 | Feb 26, 2024 |
| 8-K |
Current report
Other events
|
Feb 26, 2024 | Feb 26, 2024 |
| 8-K |
Current report
Other events
|
Feb 22, 2024 | Feb 22, 2024 |
| 8-K |
Current report
Results of operations, Regulation FD disclosure
|
Feb 14, 2024 | Feb 14, 2024 |
| 10-Q | Quarterly report | Feb 14, 2024 | Dec 31, 2023 |
| 8-K |
Current report
Regulation FD disclosure, Other events
|
Feb 12, 2024 | Feb 12, 2024 |
| 8-K |
Current report
Other events
|
Dec 18, 2023 | Dec 18, 2023 |
| 424B5 | Prospectus supplement | Dec 18, 2023 | — |
| 8-K |
Current report
Listing notice
|
Dec 15, 2023 | Dec 13, 2023 |
| 8-K |
Current report
Other events
|
Dec 7, 2023 | Dec 7, 2023 |
| 8-K |
Current report
Listing notice
|
Dec 5, 2023 | Dec 4, 2023 |
| 8-K |
Current report
Officer or director change
|
Nov 21, 2023 | Nov 20, 2023 |
| 8-K |
Current report
Results of operations, Regulation FD disclosure
|
Nov 13, 2023 | Nov 13, 2023 |
| 10-Q | Quarterly report | Nov 13, 2023 | Sep 30, 2023 |
| 8-K |
Current report
Regulation FD disclosure, Other events
|
Oct 31, 2023 | Oct 31, 2023 |
| S-1/A | Amended registration statement | Oct 27, 2023 | — |
| S-1/A | Amended registration statement | Oct 24, 2023 | — |
| 8-K |
Current report
Shareholder vote results
|
Oct 10, 2023 | Oct 9, 2023 |
| S-1 | Registration statement | Oct 4, 2023 | — |
| 8-K |
Current report
Listing notice
|
Sep 26, 2023 | Sep 20, 2023 |
| 8-K |
Current report
Material agreement
|
Sep 19, 2023 | Sep 19, 2023 |
| 424B5 | Prospectus supplement | Sep 19, 2023 | — |
| 8-K |
Current report
Results of operations, Regulation FD disclosure
|
Sep 18, 2023 | Sep 18, 2023 |
| 10-K | Annual report | Sep 18, 2023 | Jun 30, 2023 |
| DEF 14A | Proxy statement | Sep 11, 2023 | Oct 9, 2023 |
| PRE 14A | Preliminary proxy statement | Sep 1, 2023 | Oct 9, 2023 |
| 8-K |
Current report
Bylaw or fiscal year change, Shareholder vote results
|
Jun 30, 2023 | Jun 30, 2023 |
| 8-K |
Current report
Shareholder vote results
|
Jun 15, 2023 | Jun 15, 2023 |
| 8-K |
Current report
Officer or director change, Other events
|
Jun 2, 2023 | May 30, 2023 |
| 8-K |
Current report
Shareholder vote results
|
May 25, 2023 | May 25, 2023 |
| 8-K |
Current report
Results of operations, Regulation FD disclosure
|
May 11, 2023 | May 11, 2023 |
| 10-Q | Quarterly report | May 11, 2023 | Mar 31, 2023 |
| 8-K |
Current report
Shareholder vote results
|
May 9, 2023 | May 8, 2023 |
| DEFA14A | Additional proxy material | Mar 31, 2023 | — |
Showing 200 filings, the most recent 200. Main filings leave out insider and ownership forms such as Form 4; choose a type above to see them. Each form opens on SEC.gov. Older filings are on SEC EDGAR.
New to this? Read What Are SEC Filings? 10-K, 10-Q, 8-K and Other Forms Explained.
Company profile
- Industry
- Pharmaceutical Preparations (SIC 2834)
- Listed as
- HURA (Nasdaq)
- Fiscal year ends
- December 31
- Incorporated in
- NV
- Headquarters
- Tampa, FL
- SEC filer status
- Non-accelerated filer, Smaller reporting company
- SEC CIK
- 1498382
- Former names
- Kintara Therapeutics, Inc. (until Oct 22, 2024); DelMar Pharmaceuticals, Inc. (until Aug 18, 2020); Berry Only Inc. (until Jan 18, 2013)
Other Pharmaceutical Preparations companies
- ELI LILLY & Co LLY
- Johnson & Johnson JNJ
- AbbVie Inc. ABBV
- Merck & Co., Inc. MRK
- Novartis AG NVS
- Astrazeneca PLC AZN
- Abbott Laboratories ABT
- Novo Nordisk A S NVO
Source: SEC EDGAR filings. This is company-reported data, not investment advice.